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Abstract
Background: Constipation is a common occurrence in formula-fed infants. The aim of this preliminary study was
to evaluate the impact of a formula with high levels of lactose and magnesium, in compliance with the official
regulations, on stool water content, as well as a parental assessment of constipation.
Materials and methods: Thirty healthy term-born, formula-fed infants, aged 4-10 weeks, with functional
constipation were included. All infants were full-term and fed standard formula. Exclusion criteria were preterm
and/or low birth weight, organic constipation, being breast fed or fed a formula specially designed to treat
constipation. Stool composition was measured by near-infrared reflectance analysis (NIRA) and parents answered
questions about crying associated with defecation and stool consistency at baseline and after two weeks of the
adapted formula.
Results: After 2 weeks of the adapted formula, stool water content increased from 71 +/- 8.1% to 84 +/- 5.9%, (p
< 0.02). There was no significant change in the stool’s fat, protein or carbohydrate content. Parental impressions of
constipation were improved with the decrease in stool hardness (100% with hard stools at baseline, 10% after 2
weeks), pain with defecation (90% at baseline, 10% after 2 weeks), and the requirement for rectal stimulation to
achieve defecation (70% at baseline, 30% after 2 weeks, p < 0.001 for all three indicators).
Conclusions: This preliminary study suggests that an adapted formula with high levels of lactose and magnesium
increases stool water content and improves symptoms of constipation in term-born, formula-fed infants. A larger
randomized placebo-controlled trial is indicated.
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Background
Constipation is usually defined in terms of changes in
the frequency, size, and consistency of stools or diffi-
culty in defecating [1]. It is a common cause of consul-
tation, and in an observational study of 3487 infants, its
prevalence was 7.8% (95 CI 6.9-8.7) [2]. Fewer bowel
movements and/or hard stools may result in distension
of the colon, pain, irritability and crying in the infant
and this may be a cause of infantile colic [3,4]. Chronic
constipation is a source of anxiety for parents who
worry that a serious disease may cause this symptom
[5]. The term “functional constipation” is used when no
specific organic cause can be found. For younger infants,
l a x a t i v e sa r en o tu s e da n df e wi n f a n tf o r m u l a eh a v e
been designed to solve the problem and for maintenance
therapy.
Near-infrared reflectance analysis (NIRA) is a simple,
rapid, reliable method to measure fat, protein, carbohy-
drate and water content in stools and has been used for
over a decade [6-9]. In adults, it has been demonstrated
that reduced stool weights in constipated subjects are
linked to a reduction in stool water content [10].
The objective of this study is to analyze stool compo-
sition and parental assessment of symptoms of constipa-
tion with an adapted anti-constipation formula designed
to reduce hard stools.
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Patients
In the present study, constipation was characterized by
the elimination of hard stools and by at least one of the
following characteristics: excessive crying at the time of
defecation (painful defecation), difficult passage or the
need for external help to defecate [11].
Thirty constipated (according to the aforementioned
definition) formula-fed infants aged 4-10 weeks were
included. No organic cause of constipation was found in
any of them. All were fed standard formula prior to
enrolment and visited their paediatrician for constipa-
tion. All infants were full-term and had a normal birth
weight (> 3.100 kg); none had a relevant medical history
or pathological neonatal conditions. Preterm and low
birth-weight infants were excluded. None were receiving
an infant formula specially composed of modified nutri-
ents or laxatives to treat constipation.
After enrolment, all 30 infants were fed Novalac AE
(IT) (United Pharmaceuticals SA, France) for 2 weeks.
T h ec o m p o s i t i o no ft h i sf o r m u l a( T a b l e1 )h a sb e e n
adapted in compliance with EU regulations to ease con-
stipation [12,13]. Stools at baseline and after 2 weeks of
the adapted formula were assessed for faecal fat, water,
carbohydrates, and protein by NIRA. A questionnaire
about crying during defecation, stool consistency and
need for help with defecation was filled out by the par-
ents at inclusion and after 2 weeks of the adapted for-
mula. To evaluate stool consistency, the photographic
Bristol stool form scale was used: stool hardness is clas-
sified from 1 to 7 according to the stool’s appearance, in
which 1-2 corresponds to hard stools ("like nuts,
lumpy”), type 3 and 4 to intermediate, type 5-6 to soft
stools and type 7 to completely liquid stools [14].
The study was coordinated and conducted by the Gas-
troenterology unit at Vall d’Hebron Children’sH o s p i t a l
(Barcelona, Spain) and the protocol was approved by the
hospital’s medical ethics committee (Comitè Ètic Hospi-
t a lV a l ld ’Hebron). All parents granted their informed
consent to participate in the study.
Methods
The determination of fat, nitrogen, water and carbohy-
drates in the faeces was done using NIRA (near-infrared
reflectance analysis) [6-9]. The NIRA technique is based
on measuring radiation in the near-infrared spectrum
(FENIR 8820 infrared analyser, Perten, Hamburg, Ger-
many) on the surface of the sample, i.e. the matrix/sub-
strate ratio, and the infrared reflection on the faecal
surface at a given wavelength. The components mea-
sured belong to certain functional groups (CH, NH,
OH) with specific absorption bands in the near-infrared
spectrum (700-2500 nm). The spectroscopic response
(reflection) of a faecal sample is thus related to the con-
centration of the components (functional groups). The
correlation of the reflection taken at 12 wavelengths is
determined using a computerised algorithm.
Prior to the current study,w ec o m p a r e dN I R Am e a -
surements of stool fat, nitrogen, water and carbohydrate
content in eighty stool samples from infants and chil-
dren to the same measurements performed using tradi-
tional methods [6,8,15-17]. The normal values based on
our own results, which are comparable to results from
other authors, expressed as % (g/100 g of stools) are: fat:
< 5%, nitrogen: < 1.8%, carbohydrates: < 2% and water:
between 80 and 85%. However, the fat content for for-
mula-fed infants is usually higher during the first 6
months of life (between 7 and 11%) [18,19].
Statistical analysis
Non-parametric tests were used to test for changes in
quantitative measurements over time (Wilcoxon sign-
rank test) and categorical changes over time (McNemar
test). The statistical analysis was performed using the
SPSS 18.0 program (SPSS Inc, Chicago, IL).
Results
Clinical data
The results of the NIRA analysis are presented in table 2.
Water content increased significantly (71% at inclusion,
84% after 2 weeks, p < 0.01). Other parameters (fat, nitro-
gen, carbohydrates) did not change.
For all infants, stools were reported as hard at inclu-
sion (Bristol stool form scale type 1 in 23 infants and
type 2 in 7 infants.). Defecation was described as painful
(crying, irritability) in 90% of them and 70% required
Table 1 Novalac AE (IT) composition
Novalac AE Composition EU regulation*
(per 100 kcal)
For 100 ml 100kcal Min Max
Proteins (g) 1,7 2,4 2,25 3
Fats (g) 3,5 5 3,3 6,5
Linoleic acid (g) 0,6 0,8 0,3 1,2
a-linolenic acid (mg) 56,4 79,8
Palmitic acid(g) 0,78 1,2
Carbohydrates (g) 8,1 11,4 7 14
Lactose 8,1 11,4 3,5
Energy (kcal) 70,7 100 60 75
(kJ) 295.6 418,0
Minerals
Calcium (mg) 70 99 50
Phosphorus (mg) 35,7 50,5 25 90
Calcium/Phosphorus 2
Magnesium (mg) 9,1 12,9 5 15
* EU Directive 1991/321 CE on infant & follow-on formula, in force when the
study was performed.
Infante et al. Nutrition Journal 2011, 10:55
http://www.nutritionj.com/content/10/1/55
Page 2 of 4help to defecate. At the end of the follow-up period,
stools had a soft consistency in 90% of the infants (Bris-
tol stool form scale type 5 in 15 infants and type 6 in 12
infants) (p < 0.0001), 90% presented no pain or discom-
fort (p < 0.0001) and 70% did not require help to defe-
cate (p < 0.001) (see Table 3).
Discussion
Breast-fed infants have significantly more stools per day
than formula-fed ones and only a few have hard stools
(1.1% of exclusively breast-fed infants vs. 9.2% of for-
mula-fed infants [20,21]). The frequency of painful defe-
cation in constipated children varies from 89% [22] to
40-50% [23,24] depending on the series reported. Fewer
bowel movements due to prolonged transit time may
result in distension of the gut, irritability and crying,
and this may be a reason for inclusion in the associated
group of infantile colic [2-4]. Tunc et al. report that, in
t h ef i r s t2m o n t h so fl i f e ,t h em e d i a nn u m b e ro fs t o o l s
is lower in colicky infants than in those who do not
have colic (p = 0.0001) [18].
Several hypotheses have been proposed to explain the
softer stools associated with breast feeding. First,
increased levels of gastric inhibitory polypeptide, moti-
lin, neurotensin, vasoactive intestinal peptide secretions
in formula-fed infants compared to breast-fed infants
may explain their slower intestinal transit [25]. Second,
more frequent breast feedings may stimulate the gastro-
colic reflex resulting in more frequent defecation. Third,
human milk contains large amounts of prebiotic
oligosaccharides. Fourth, fat composition may play a
role in softer stools. In breast milk and in most infant
formulae, fats represent nearly 50% of energy content.
The main saturated fatty acid in breast milk is palmitic
acid (C16:0), with more than 70% esterified to the sn-2
position, whereas in regular infant formulae 88-94% of
the palmitic acid is esterified to the sn-1,3 position.
Lipolysis at the sn-1 and sn-3 positions requires pan-
creatic lipase, which is deficient in the first 6 months of
life. The result is relative fat malabsorption, which may
react with luminal calcium to form calcium soaps pro-
ducing hard stools [25,26].
Previous NIRA studies have shown lower stool fat in
breast-fed infants: 2.6% in breast-fed infants versus 7-
11% in formula-fed infants younger than 6 months and
less than 5% in formula-fed infants older than 6 months
[9,10]. Our study confirmed the relative steatorrhoea in
formula-fed infants [18,19]. Feeding a formula contain-
ing a high concentration of sn-2 palmitic acid caused
softer stools but no change in stool frequency in one
study [19] and decreased fatty acid soaps in another
study [27]. We saw no change in stool fat content in the
current study, suggesting that the improvement in con-
stipation was not related to changes in fat metabolism.
A clinical trial by Chao et al. of 93 infants (average
age 3.8 months) showed that the same formula we used
in the current study (Novalac AE/IT) improved infant
constipation. The infants receiving this formula had
increased stool weight and decreased abdominal disten-
sion and irritability compared to infants receiving pla-
cebo [28]. Our study adds to these results and includes
objective NIRA data.
The two additives to the adapted formula likely impact
stool water content through different mechanisms. Lac-
t o s eh a sp r e b i o t i ce f f e c t si nt h a ti ti sn o tc o m p l e t e l y
absorbed in young infants and stimulates the growth of
commensal bacteria. Non-hydrolyzed lactose reaches the
colon, where it is metabolized by anaerobic microorgan-
isms, producing an osmotic laxative effect as it attracts
water into the intestinal lumen [29-32]. Magnesium, due
to its osmotic properties, increases the laxative effect
and stimulates intestinal motility by inducing cholecys-
tokinin secretion [33].
In conclusion, this non-randomized, non-placebo-
controlled preliminary study demonstrates that the use
of an infant formula with high lactose and magnesium
concentrations may increases t o o lh y d r a t i o n ,w h i c h
softens the stools with a corresponding clinical
improvement. Thus, constipated infants who present
hard stools may benefit from a change from standard
formula to this specifically adapted formula. Larger
randomized clinical trials on the efficacy of this for-
mula are needed.
Table 2 Stool NIRA at inclusion and follow-up (2 weeks).
NIRA Normal
values
Inclusion After
2 weeks
P value*
Fat 7-11 (under
6 months)
< 5 (over
6 months)
9.12 ± 3 8.35 ± 2.1 NS
Nitrogen < 1.8 1.83 ± 0. 24 1.75 ± 0.22 NS
Carbohydrates < 2 2 ± 0.94 1.96 ± 0.76 NS
Water 80-85 71 ± 8 84 ± 5.93 < 0.01
Values are expressed as % (wt/wt of stools).
* Wilcoxon Sign-rank test
Table 3 Parental assessments
Inclusion After 2 weeks p value *
Stool consistency Hard
Soft
100% 10%
90%
<0.0001
Pain or difficulty Yes
No
90%
10%
10%
90%
<0.0001
External help need Yes
No
70%
30%
30%
70%
< 0,001
*McNemar’s test
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